#Wegovy

TWICE Jeongyeon's weight loss transformation has gone viral with 80k views. Explore the discussion surrounding her health recovery and the Wegovy debate in K-pop.

Novo Nordisk warns of near-term headwinds in international operations for 2026. Despite high demand for Wegovy, pricing and supply issues pose risks to growth.

Single’s Inferno star Lee Si An opens up about her grueling experience with Wegovy, describing a 'zombie-like' state and severe nausea that forced her to quit.

Novo Nordisk (NVO) stock jumped 8% following FDA approval for the oral pill version of its weight-loss drug Wegovy. The move is expected to significantly broaden patient access and intensify competition with Eli Lilly.

The US FDA has approved the first-ever pill form of Novo Nordisk's blockbuster weight-loss drug, Wegovy. Showing comparable results to the injection in trials, the daily pill is set to launch in January 2026.

The FDA has approved a once-daily pill version of Novo Nordisk's blockbuster weight-loss drug Wegovy, offering a new option versus the weekly shot and escalating competition with Eli Lilly.

Korean star Pung Ja's recent weight loss is more than a glow-up. Her rejection of Wegovy for lifestyle changes signals a major shift in the wellness market.